Inhibition of Influenza Entry by Organosilicon Compounds
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Aleksandar Antanasijevic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Virus Internalization, Hydroquinones, Organosilicon Compounds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, This study was partially supported by the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust to M.C. and B.M. and….
Abstract (Originalsprache)
Hemagglutinin (HA) plays a critical role in the entry of influenza and thus HA is a target for the development of entry inhibitors as antivirals. One of the first small molecule inhibitors of influenza entry to be described was tert ‐butylhydroquinone (TBHQ), a commonly used antioxidant. This compound was shown to inhibit influenza containing Group 2 HA, such as H3 and H7 HA circulating in humans and avians. One limitation of TBHQ is the propensity to oxidize in solution, resulting in a less active form of the compound. Recently, our group has shown that the reactivity of TBHQ may be significantly reduced through substitution of one hydroxyl group with a methoxy, resulting in a concurrent increase in potency and a decrease in cytotoxicity. In this study, we demonstrate that the inhibitory capacity can be further improved by introducing tri‐ methyl silane (TMS) in place of the tert‐ butyl (TB) group. Silicon‐based derivatives of TBHQ exhibited increased stability in solution compared to the parent TBHQ compound. Analysis using NMR spectroscopy revealed similar interaction patterns for the original and engineered compounds, although the TMS group was creating stronger hydrophobic contacts within the binding pocket on HA. Strikingly, TMS‐containing compounds exhibited increased in vitro activity against pseudotyped and live influenza viruses carrying Group 2 HAs. In summary, we applied a novel strategy for chemical optimization of antiviral compounds and demonstrated that this approach can improve their stability and their potency for the target protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois, USA.
- Global Health Institute, Swiss Federal Institute of Technology EPFL, Lausanne, Switzerland.
- Department of Chemistry, University of Illinois at Chicago, Chicago, Illinois, USA.
- Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.
- Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, Illinois, USA.
Förderung
- NIAID NIH HHS
- This study was partially supported by the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust to M.C. and B.M. and…
Zitieren
APA
Antanasijevic, A., Haferman, N. J., Shimon, A., Tundup, S., Anirudhan, V., Rong, L., Manicassamy, B., Wardrop, D., & Caffrey, M. (2025). Inhibition of Influenza Entry by Organosilicon Compounds. Journal of Medical Virology. https://doi.org/10.1002/jmv.70436
Vancouver
Antanasijevic A, Haferman NJ, Shimon A, Tundup S, Anirudhan V, Rong L, et al. Inhibition of Influenza Entry by Organosilicon Compounds. Journal of Medical Virology. 2025. doi:10.1002/jmv.70436
BibTeX
@article{Antanasijevic2025,
author = {Antanasijevic, Aleksandar and Haferman, Nicholas J and Shimon, Amir and Tundup, Smanla and Anirudhan, Varada and Rong, Lijun and Manicassamy, Balaji and Wardrop, Duncan and Caffrey, Michael},
title = {Inhibition of Influenza Entry by Organosilicon Compounds},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70436}
}
EUVIMED